Cara Therapeutics Announces CMS Grants TDAPA to KORSUVA™ (difelikefalin) Injection

3 years ago

KORSUVA receives TDAPA reimbursement beginning April 2022 U.S. commercial launch on track for early second quarter 2022 STAMFORD, Conn., Dec.…

Checkmate Pharmaceuticals Strengthens Board of Directors with Appointment of Joy Yan, M.D., Ph.D.

3 years ago

Nilesh Kumar, Ph.D. departs Board of Directors upon transition to new role at Wellington ManagementCAMBRIDGE, Mass., Dec. 20, 2021 (GLOBE…

Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Phase 2 Multi-Indication Trial Using Vidutolimod

3 years ago

CAMBRIDGE, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused…

Microbix Launches Multiplex Respiratory PCR-Test Control

3 years ago

Helping Ensure Workflow Accuracy of Tests for COVID, Flu A, Flu B, and RSVMISSISSAUGA, Ontario, Dec. 20, 2021 (GLOBE NEWSWIRE)…

Reviva Pharmaceuticals to Participate in the Upcoming January Virtual Investor Conferences

3 years ago

CUPERTINO, Calif., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage…

Talaris Therapeutics Announces Addition to the Nasdaq Biotechnology Index

3 years ago

BOSTON and LOUISVILLE, Ky., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc., (Nasdaq: TALS), a late-clinical stage cell therapy…

Rentschler Biopharma reports strong growth and continues hiring at all three sites

3 years ago

Over 300 new team members in 2021, additional new positions planned at all sitesRentschler Biopharma again named one of “most…

CMR Surgical expands into the Middle East

3 years ago

CMR Surgical expands into the Middle East Versius being used to perform minimal access surgery (MAS) in several hospitals across…

ObsEva Added to the NASDAQ Biotechnology Index

3 years ago

GENEVA, Switzerland December 20, 2021 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies…